Recent Quarter Total Invested
$69,689
Recent Quarter Institutional Ownership Percentage
8.69%
Total Invested of Last Quarter
$89,149
Ownership Percentage of Last Quarter
6.33%
Bone Biologics Corporation Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| UBS GROUP AG | 08/14/2024 | 33,707 | $41,123 | 5,517.83% | 5.10% |
| HRT FINANCIAL LP | 08/12/2024 | 17,519 | $21,000 | 100.00% | 2.65% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 5,789 | $7,063 | 36.21% | 0.88% |
| MFA WEALTH ADVISORS, LLC | 07/22/2024 | 403 | $492 | 100.00% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 9 | $11 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
Bone Biologics Corporationinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of BBLG shares?
During the previous two years, 6 institutional investors and hedge funds held shares of Bone Biologics Corporation. The most heavily invested institutionals were:
UBS Group AG: 33,707
HRT FINANCIAL LP: 17,519
Tower Research Capital LLC (TRC): 5,789
BANK OF AMERICA CORP /DE/: 9
WELLS FARGO & COMPANY/MN: 0
ARMISTICE CAPITAL, LLC: 0
-
What percentage of Bone Biologics Corporation stock is owned by institutional investors?
8.69% of Bone Biologics Corporation stock is owned by institutional investors.
-
How much institutional buying is happening at BBLG ?
Institutional investors have bought a total of 57,024 shares in the last 24 months. This purchase volume represents approximately $75,842 in transactions.